SecBot SecBot
Insider Cluster (3 insiders) ·Filed Aug 10, 2026

SYRE

Spyre Therapeutics, Inc.
BEARISH
Impact 5/10
Horizondays Processed3mo ago
Insider cluster: 3 insiders, $0.9M total
Actionable Insight ▼ Bearish

The insider sales are small relative to market cap and likely routine portfolio diversification or tax-related selling, especially given the stock's recent strong performance. However, the cluster of C-suite and director sales in a narrow window is a mild cautionary signal. Monitor for any upcoming negative catalysts (e.g., clinical data readouts, regulatory updates) that could explain the timing. The stock's strong historical momentum suggests the market may not react negatively to these sales alone.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$102.74
T+0 close · Aug 10, 2026 · via day close
Latest settled
−3.60%
T+60 · $99.04
Vs SPY
−3.11%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 11 $102.74entry
  2. T+1 · 3mo ago +1.31%α +1.06% · $104.09
  3. T+5 · 3mo ago +4.94%α +5.35% · $107.82
  4. T+20 · 2mo ago −15.39%α −14.33% · $86.93
  5. T+60 · 13d ago −3.60%α −3.11% · $99.04

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three insiders at Spyre Therapeutics, including the CEO and CFO, sold shares totaling $920K over a one-week window. Director Albers Jeffrey W. executed the bulk of the sales ($2.4M across multiple transactions on August 7), including derivative exercises followed by open-market sales.

Key Financial Metrics

Direction
selling
Total Value
$920.0K
Insiders
3

Key Facts

  • Three insiders sold shares totaling $920K in a 7-day window ending August 7, 2026.
  • Director Albers Jeffrey W. sold $2.4M worth of shares on August 7, including derivative exercises and open-market sales.
  • CEO Cameron sold 800 shares at $93.97 for $75K; CFO Burrows sold 100 shares at $97.10 for $10K.
  • Total insider sales represent ~0.01% of the $9.3B market cap, which is below the 0.1% threshold for materiality.

Financial Impact

Total insider sales of $920K, or approximately 0.01% of market cap, are trivial in absolute and relative terms.

insider_sales

Risk Factors

  • Insider sales could signal a lack of confidence in near-term prospects, though the dollar amounts are too small to be definitive.
  • The stock's high valuation ($9.3B market cap for a pre-revenue biotech) creates downside risk if pipeline catalysts disappoint.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-SYRE-1786411948947

Track record

36 reports on SYRE

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+60. Best: +54.27% at T+60 after the Apr 13, 2026 report. 14 of 20 went positive at some point.

Filters
  1. Nov 3, 202613d ago 8-K Neutral 5/10 No price data
  2. Nov 3, 202613d ago Press Release Bearish 5/10 Entry $99.04 Now $99.37 −0.33% settles Feb 2
  3. Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
  4. Oct 9, 20265w ago SC 13D/A Neutral 3/10 Entry $85.90 Now $99.37 +15.68% settles Jan 7
  5. Oct 7, 20265w ago 8-K Bearish 5/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
  6. Oct 6, 20265w ago 424B5 Bearish 6/10 Entry $80.85 Now $99.37 −22.91% settles Jan 4
  7. Oct 5, 20266w ago Press Release Bearish 6/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
  8. Oct 5, 20266w ago 424B5 Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
  9. Oct 5, 20266w ago Press Release Bearish 5/10 Entry $80.11 Now $99.37 −24.04% settles Dec 31
  10. Oct 2, 20266w ago Insider Cluster Bearish 4/10 Entry $92.72 Now $99.37 −7.17% settles Dec 30
Showing 10 of 36

US Market Status

Market Closed · Opens Wed (10h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 10, 2026